UNH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03
Fiyat $418.09
Piyasa Değeri (MRQ) $378.37B
P/E (TTM) 26.8
Hisse Başına Kâr (TTM) $15.58
Gelir (TTM) $450.13B
Temettü Verimi 2.1%
ROE (TTM) 13.8%
D/E Borç/Özsermaye (MRQ) 0.7
52 Haftlık Aralık $256–$462

UNH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04
aralık
çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Hisse bölünmeleri 5
Ex-tarihi Bölünme Tür
31 Mayıs 2005 2-for-1 İleri
19 Haziran 2003 2-for-1 İleri
26 Aralık 2000 2-for-1 İleri
11 Mart 1994 2-for-1 İleri
16 Eylül 1992 2-for-1 İleri

UnitedHealth Group Incorporated Common Stock (DE) Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

UnitedHealth Group Incorporated is an American multinational company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's ninth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.

UnitedHealth Group had a market capitalization of more than $300 billion as of year-end 2025. The company is the largest health insurer in the United States, insuring over 50 million people, and operates globally.

UnitedHealth Group has faced numerous investigations, lawsuits, and fines, including SEC enforcement for stock option backdating, Medicare over-billing, unfair claims practices, mental health treatment denials, and anticompetitive behavior.

History

1970s–1990s

UnitedHealth Group originated in late 1974, when Minnesota-based Charter Med Incorporated was founded by Richard Taylor Burke. It originally processed claims for doctors at the Hennepin County Medical Society. UnitedHealthcare Corporation was founded in 1977 to purchase Charter Med and create a network-based health plan for seniors. It became a publicly traded company in 1984 and changed its name to UnitedHealth Group in 1998.

In 1988, UnitedHealthcare started its first pharmacy benefit management, through its Diversified Pharmaceutical Services subsidiary. It managed pharmacy benefits delivered both through retail pharmacies and mail. The subsidiary was sold to SmithKline Beecham in 1994 for $2.3 billion.

In 1994, UnitedHealthcare acquired Ramsey-HMO, a Florida insurer. In 1995, the company acquired The MetraHealth Companies Inc. for $1.65 billion. MetraHealth was a privately held company formed by combining the group healthcare operations of The Travelers Companies and MetLife. In 1996, UnitedHealthcare acquired HealthWise of America, which operated HMOs in Arkansas, Maryland, Kentucky and Tennessee.

In 1998, the company was reorganized as the holding company for hitherto independent companies UnitedHealthcare, Ovations, Uniprise, Specialized Care Services, and Ingenix and rebranded as "UnitedHealth Group". Also in 1998, UnitedHealth Group acquired HealthPartners of Arizona, operator of Arizona's largest AHCCCS provider.

2000s

In 2001, EverCare, a UnitedHealth Group subsidiary, merged with LifeMark Health Plans In 2002, UnitedHealth Group acquired GeoAccess and Medicaid insurance company AmeriChoice. In 2003, UnitedHealth Group acquired Mid Atlantic Medical Services, an insurer serving Maryland, Washington D.C., Virginia, Delaware and West Virginia. Also in 2003, UnitedHealth Group acquired Golden Rule Financial, a provider of health savings accounts. On July 21, 2003, Exante Bank started operating in Salt Lake City, Utah, as a Utah state-chartered industrial loan corporation. It changed its name to OptumHealth Bank in 2008 and to Optum Bank in 2012.

In April 2004, UnitedHealth Group acquired Touchpoint Health Plan, a Wisconsin health plan. In July 2004, the company acquired Oxford Health Plans.

In December 2005, the company acquired PacifiCare Health Systems. It agreed to divest parts of PacifiCare's commercial health insurance business in Tucson, Arizona and Boulder, Colorado to satisfy antitrust regulator concerns, and also agreed to end its network access agreement with Blue Shield of California. The Tucson business was sold to Cigna. The company acquired Prescription Solutions, another pharmacy benefits manager, as part of its acquisition of PacifiCare Health Systems. This business was later rebranded OptumRx.

In February 2006, the company acquired John Deere Health Care. The same year, William W. McGuire stepped down as chairman and director due to his involvement in the employee stock options scandal. He was replaced by CEO Stephen Hemsley who had served as president and COO and a member of the board of directors. McGuire's exit compensation from UnitedHealth was anticipated to be $1.1 billion, but he only received $618 million after returning $420 million in stock options.

In February 2008, the company acquired Sierra Health Services for $2.6 billion. As part of the transaction, to obtain regulatory approval, 25,000 customers were sold to Humana. In July 2009, UnitedHealth Group agreed to acquire Health Net's Northeast licensed subsidiaries for up to $570 million in payments spread out over two years.

2010s

Through 2010 and into 2011, senior executives of the company met monthly with executives of other health insurers to limit the effect of the health care reform law. In July 2010, Ingenix acquired Picis Clinical Solutions, Inc., a health information provider for the high-acuity areas of hospitals. In 2011, Logistics Health, Inc. of La Crosse, Wisconsin, was acquired by OptumHealth. In September 2014, the office buildings where LHI is based were sold to UnitedHealth Group for $45 million. In February 2012, the company acquired XLHealth, a sponsor of Medicare Advantage health plans with a primary focus on medicare recipients with special needs such as those with chronic illness and those eligible for Medicaid ("dual eligibles"). In October 2012, UnitedHealth Group and Amil Participações, one of the biggest Brazilian health insurance companies, completed the first phase of their merger.

In February 2014, Optum secured a majority stake in the Washington, D.C.–based startup Audax Health. Audax's CEO, Grant Verstandig, continued running the firm alongside COO David Ko. In October 2014, Optum Health acquired the health services unit of Alere for $600 million cash.

In March 2015, it was announced that CatamaranRx would be acquired by OptumRx. In April 2016, the company announced it was pulling out of all but a "handful" of state healthcare exchanges provided under Affordable Care Act and will continue to sell only in three states in 2017.

In 2017, UnitedHealth's Optum unit acquired Rally Health, a company started by Audax Health's executives. Prior to acquisition, in 2015, UnitedHealth supported Rally Health as a majority investor, and through enrolling more than 5 million UnitedHealth policy holders in Rally Health's flagship product, Rally. The close relations between UnitedHealth, Audax Health and Rally Health follows a close personal relationship between Grant Verstandig (Audax and Rally) and UnitedHealth's President and CFO at the time, David Wichmann.

In June 2019, UnitedHealth's Optum division acquired DaVita Medical Group from DaVita, Inc. for $4.3 billion. That year, the company also agreed to acquire Equian for $3.2 billion. On June 19, 2019, UnitedHealth acquired the online patient community platform PatientsLikeMe for an undisclosed amount and it will be incorporated into UnitedHealth Group's research division.

In November 2019, Andrew Witty was named president of UnitedHealth Group, in addition to his role as chief executive of the company's Optum division.

2020s–present

UnitedHealth announced in March 2022 that it would acquire LHC Group for $5.4 billion. The deal will expand its home health capabilities by combining LHC's services with UnitedHealth's Optum unit.

In 2022, UnitedHealth Group said there would be no out-of-pocket costs for albuterol, epinephrine, glucagon, insulin, and naloxone for fully insured members starting in 2023. The discounts were guaranteed for less than a quarter of UnitedHealthcare's membership and did not extend to those enrolled in UHC's Medicare Advantage and Medicaid plans.

In 2023, UnitedHealthGroup announced it would move its headquarters from Minnetonka to Eden Prairie, Minnesota.

In February 2024, UnitedHealth Group completed the sale of its operations in Brazil.

In January 2021, UnitedHealth announced the acquisition of Change Healthcare, the largest health payments platform in the US, which the US Justice Department tried to block on antitrust grounds in February 2022; the sale went through by September. 18 months later, in February 2024, the subsidiary was brought completely down by the 2024 Change Healthcare ransomware attack, and the Justice Department announced that it was opening a new antitrust and Medicare overcharging probe. Despite making a ransomware payment, services remained down or incomplete for months. The CEO, Andrew Witty, was called before the US House and US Senate to testify about the cyberattack and DoJ concerns. In late April 2024, the Senate held a hearing concerning the cyberattack and UnitedHealth's response. Andrew Witty went before the Senate stating that there needed to be a strong digital security system in place along with an adequate backup plan. UnitedHealth revealed the hackers did gain access to patient information, but the Senate was informed the company is not yet aware of the extent of the data breach.

Killing of Brian Thompson

On December 4, 2024, Brian Thompson, the CEO of UnitedHealth Group's insurance subsidiary UnitedHealthcare, was killed in a shooting in New York City. The shooting occurred outside the New York Hilton Midtown, where UnitedHealth Group was hosting an investor event. Reactions to the shooting on social media were defined by resentment and criticism of UnitedHealthcare, the American health insurance system, and widespread disdain towards Thompson. Police later arrested a suspect, Luigi Mangione, and charged him with murder. Tim Noel joined UnitedHealthcare in 2007 and succeeded Brian Thompson as the CEO. Prior to becoming CEO, Noel was in charge of UnitedHealthcare's Medicare Advantage plans.

Further events

In November 2025, Scott Gottlieb, the former commissioner of the Food and Drug Administration, joined UnitedHealth Group's board of directors.

In June 2026, UnitedHealth Group announced plans to invest $3 billion in artificial intelligence in 2026 and 2027.

In October 2026, UnitedHealth Group reported third-quarter revenue of about $112.7 billion and adjusted earning of $4.69 per share. Following these results, the company raised its full-year adjusted earnings forecast to at least $20.50 per share.

Organizational structure

UnitedHealth Group has about 2700 subsidiaries and affiliates worldwide, the highest profile being Optum and UnitedHealthcare.

Optum

Formed in 2011, Optum says that it provides "data and analytics, pharmacy care services, population health, healthcare delivery, and healthcare operations".

It is organized into three businesses:

OptumHealth – provides primary and secondary care.

OptumInsight – provides data analytics, technology, and operations services.

OptumRX – provides pharmacy services.

UnitedHealthcare

UnitedHealthcare (UHC) is an insurance and managed care company with three main divisions:

UnitedHealthcare Employer and Individual – provides health benefit plans and services for large national employers and individuals.

UnitedHealthcare Medicare and Retirement – provides health and well-being services to individuals age 65 and older.

UnitedHealthcare Community and State – serves state programs that care for the economically disadvantaged, the medically underserved, and people without the benefit of employer-funded health care coverage, in exchange for a monthly premium per member from the state program.

Finance

For the fiscal year 2022, UnitedHealth Group reported earnings of US$20.64 billion, with an annual revenue of US$324.16 billion. UnitedHealth Group's 2023 revenue grew by $47.5 billion, or 14.6%, on annualized revenue of $371.6 billion. Operating income for 2023 was $32.4 billion (up 13.8%). Cash flows from operations were $29.1 billion. UnitedHealth Group’s 2024 revenues grew $28.7 billion or 8% year-over-year to $400.3 billion. Earnings from operations of $32.3 billion compared to $32.4 billion in 2023. Cash flows from operations were $24.2 billion.

Lobbying and political activity

In 2009, according to OpenSecrets, people affiliated with UnitedHealth Group gave $4.77 million to political candidates and groups. The Affordable Care Act was being discussed in Congress at the time and was subsequently passed in the first quarter of 2010. In 2010 UnitedHealth Group hired nine different lobbying firms to work on its behalf. In addition, its corporate political action committee (PAC), called United for Health, spent an additional $1 million on lobbying activities. UnitedHealth Group subsequently spent $4.11 million to $4.75 million from 2011 to 2021.

The Lewin Group

The Lewin Group is a policy research and consulting firm that provides an economic analysis of health care and human services issues and policies. The organization has existed for about 40 years and has maintained a nonpartisan reputation through the many ownership changes that have occurred over that time. The Lewin Group was purchased in 2007 by Ingenix, a subsidiary of UnitedHealth Group, but alleges editorial and analytical "independence" from UnitedHealth Group, its parent company. The Lewin Group discloses its ownership in its reports and on its website. While the Lewin Group does not advocate for or against any legislation, both Democratic and Republican politicians frequently cite the firm's studies to argue for and against various U.S. healthcare reform proposals. For example, Democratic Senator Ron Wyden uses Lewin Group estimates to cite the feasibility of his Healthy Americans Act. Former U.S. Representative Eric Cantor, the former House Republican Whip, has referred to the organization as "the nonpartisan Lewin Group" in arguing against government-funded health insurance proposals.

Several Lewin studies have been used to argue both for and against the inclusion of a public option in national health reform. Lewin clients who often cite its findings include The Commonwealth Fund, which, in 2009, held up a Lewin study it commissioned to advocate for a public plan. The report showed that legislative proposals would achieve nearly universal coverage and "estimated that a public plan could offer small businesses insurance that is at least 9 percent cheaper than current small-business policies".

However, the Lewin Group has acknowledged that clients sometimes choose to keep the results of studies they have commissioned private. Indeed, Lewin Group Vice President John Sheils told The Washington Post that "sometimes studies come out that don't show exactly what the client wants to see. And in those instances, they have [the] option to bury the study."

Criticism and controversies

SEC investigation

In 2006, the U.S. Securities and Exchange Commission (SEC) began investigating the conduct of UnitedHealth Group's management and directors, for backdating of stock options. Investigations were also started by the Internal Revenue Service and prosecutors in the U.S. attorney's office for the Southern District of New York, who subpoenaed documents from the company. The investigations came to light after a series of probing stories in the Wall Street Journal in May 2006, discussing the apparent backdating of hundreds of millions of dollars' worth of stock options by UHC management. The backdating apparently occurred with the knowledge and approval of the directors, according to the Journal. Major shareholders have filed lawsuits accusing former New Jersey governor Thomas Kean and UHC's other directors of failing in their fiduciary duty. On October 15, 2006, CEO William W. McGuire was forced to resign, and relinquish hundreds of millions of dollars in stock options.

On December 6, 2007, the SEC announced a settlement under which McGuire was to repay $468 million, including a $7 million civil penalty, as a partial settlement of the backdating prosecution. He was also barred from serving as an officer or director of a public company for ten years. This was the first time in which the little-used "clawback" provision under the Sarbanes-Oxley Act was used against an individual by the SEC. The SEC continued its investigations even after it in 2008 settled legal actions against both UnitedHealth Group itself and its former general counsel.

American Chiropractic Association lawsuit

In June 2006, the American Chiropractic Association filed a national class-action lawsuit against the American Chiropractic Network (ACN), which is owned by UnitedHealth Group and administers chiropractic benefits, and against UnitedHealth Group itself, for alleged practices in violation of the federal Racketeer Influenced and Corrupt Organizations Act (RICO). The Missouri Department of Insurance, Financial Institutions and Professional Registration determined that UnitedHealth Group violated state insurance laws, so levied $536,000 in fines and ordered more than 50,000 cases re-opened; any improperly denied claims must have been reimbursed with interest for chiropractors and patients.

OptumInsight, a.k.a. Ingenix lawsuit

In February 2008, New York State Attorney General Andrew Cuomo announced an industry-wide investigation into a scheme by health insurers to defraud consumers by manipulating reasonable and customary rates. The announcement included a statement that Cuomo intended "to file suit against Ingenix, Inc., its parent UnitedHealth Group, and three additional subsidiaries". Cuomo asserted that his investigation found that rates found in a database of health care charges maintained by Ingenix were lower than what he determined was the actual cost of certain medical expenses. Cuomo said this inappropriately allowed health insurance companies to deny a portion of provider claims, thereby pushing costs down to members.

On January 13, 2009, Ingenix announced an agreement with the New York State attorney settling the probe into the independence of the health pricing database. Under the settlement, UnitedHealth Group and Ingenix would pay $50 million to finance a new, non-profit entity that would develop a new healthcare pricing database. Ingenix would discontinue its medical pricing databases when the new entity makes its product available. The company acknowledged the appearance of a conflict of interest but admitted no wrongdoing.

On January 15, 2009, UnitedHealth Group announced a $350 million settlement of three class action lawsuits filed in Federal court by the American Medical Association, UnitedHealth Group members, healthcare providers, and state medical societies for not paying out-of-network benefits. This settlement came two days after a similar settlement with Cuomo.

On October 27, 2009, Cuomo announced the creation of FAIR Health, an independent, non-profit organization that would develop a nationwide database for consumer reimbursement, as well as a website where consumers would be able to compare prices before choosing doctors. To fund FAIR Health, the Attorney General's office secured nearly $100 million from insurers such as Aetna, UnitedHealth Group, and Anthem Inc.

PacifiCare fine in California

In 2008, the California Department of Insurance took action against UnitedHealthcare's subsidiary PacifiCare Health Systems, acquired in 2005, ultimately fining UnitedHealthcare around $173 million for an estimated over 900,000 violations of the Unfair Insurance Practices Act; by 2019, the case was still being disputed in court, with the possibility of affirming $91 million in penalties.

Medicare overbilling lawsuit

A whistleblower lawsuit filed in 2011 charged UnitedHealth Group's data analytics division with assisting in defrauding Medicare by boosting risk adjustment scores from Medicare Advantage companies. The suit alleged that UnitedHealth Group subsidiary Ingenix (now OptumInsight) "defrauded the United States of hundreds of millions – and likely billions – of dollars". Former UnitedHealth executive Benjamin Poehling brought the suit under the False Claims Act. The government said it would proceed on claims against two healthcare companies, UnitedHealth and its Texas subsidiary WellMed Medical Management. In February 2017, a federal judge unsealed the suit after the Department of Justice announced it would join the case.

CMS fine over Medicare Part D

In 2017, the Centers for Medicare and Medicaid Services (CMS) fined UnitedHealthcare $2.5 million after discovering issues in Medicare Part D leading to delays or denials in a 2016 audit.

2018 New Jersey fine

In 2018, the New Jersey Department of Banking and Insurance fined UnitedHealthcare $2.5 million due to various compliance issues; this was the largest fine against a licensee in nine years.

Richard Cole, and others v. UnitedHealthcare

On April 29, 2019, Judge Robert N. Scola Jr. of the United States District Court for the Southern District of Florida, a cancer survivor, recused himself from a case against UnitedHealthcare, stating that the company's denial of treatment was "immoral and barbaric", and that his opinions regarding the company would prevent him from "deciding this case fairly and impartially".

Mental health treatment lawsuit

As reported by openminds.com:

On September 13, 2019, three addiction and mental health treatment centers sued United Behavioral Health (UBH), UnitedHealthcare's mental health subsidiary. The centers alleged that UBH wrongfully denied $5 million in behavioral health treatment claims for self-insured and fully insured employer health plans for residential and outpatient treatment from 2011 to 2017. The case involves claims for 157 employer group health plan members, including children.

Pennsylvania lawsuit

In 2019, UnitedHealthcare paid a $1 million penalty to settle Pennsylvania regulators' allegations that the company violated state and federal laws when paying medical claims, particularly for patients seeking treatment for autism and substance use disorders. The regulators also compelled the company to pay restitution for wrongly denied or delayed claims and to spend $800,000 on an outreach campaign to notify consumers of their mental health and substance use disorder benefits.

Dispute with TeamHealth

In late 2021, Tennessee-based physician network TeamHealth, a subsidiary of the private equity company Blackstone Inc., sued UnitedHealthcare in the 8th District Court of Clark County, Nevada, alleging the insurer underpaid claims to three of TeamHealth's Nevada-based affiliates. In November 2021, the jury unanimously found United guilty of "oppression, fraud, and malice" in its conduct and awarded TeamHealth $2.65 million in compensatory damages. In December, the jury reconvened to determine punitive damages and awarded TeamHealth $60 million. TeamHealth plans to pursue similar legal action against United and other insurers in New Jersey, Pennsylvania, New York, Florida, Oklahoma, and Texas.

Medicare Advantage overbilling

An October 2021 New York Times report identified UnitedHealth in a list of Medicare insurers accused of over-billing. According to the Inspector General, a whistleblower came forward, so the U.S. government went after UnitedHealth for over-billing Medicare. Executives at UnitedHealth Group told workers to mine old medical records for more illnesses, to identify diagnoses of serious diseases that might have never existed, inflating bills paid by the federal government's Medicare Advantage program.

A study by the Kaiser Family Foundation found that in 2021, Medicare Advantage programs provided insurers with double the gross margin of insurance for individuals, groups, or Medicaid Managed Care.

In July 2024, the Wall Street Journal concluded that UnitedHealth was the worst offender among private insurers who made dubious diagnoses in their clients in order to trigger large payments from the government's Medicare Advantage program. The patients often did not receive any treatment for those insurer-added diagnoses. The report, based on Medicare data obtained from the federal government under a research agreement, calculated that diagnoses added by UnitedHealth for diseases patients had never been treated for had yielded $8.7 billion in payments to the company in 2021 – over half of its net income of $17 billion for that year.

In July 2025, the Wall Street Journal reported that United States Department of Justice officials were interviewing former UnitedHealth employees in connection with the investigation, and later that month, UnitedHealth confirmed that it was under criminal and civil federal investigation for its Medicare practices. The company said it cooperated with those probes after reaching out to the DOJ.

Change Healthcare acquisition

In February 2022, the United States Department of Justice sued to stop UnitedHealth Group's $8 billion acquisition of Change Healthcare, arguing that the deal would give UnitedHealth access to its competitors' data and ultimately push up healthcare costs. The Justice Department said that UnitedHealth knew that access to claims would give it a view into rival health plans at Humana, Anthem Inc, CVS Health, Aetna, and Cigna. A U.S. judge rejected the department's bid in September. Following the completion of the acquisition in October 2022, the parties agreed that the appeal would be voluntarily dismissed, with no reasons provided by the Justice Department for dropping the appeal.

Insider trading lawsuit

In May 2024, the City of Hollywood Firefighters Pension Fund sued UnitedHealth Group for alleged insider trading, claiming that then-Board Chair and future chairman and CEO Stephen Hemsley and then-UnitedHealthcare CEO Brian Thompson had sold millions of dollars worth of shares in UHG since October 2023 with foreknowledge that the United States Department of Justice were investigating them.

Use of algorithmic AI model to deny claims

UnitedHealth Group has faced a lawsuit over its use of an algorithmic AI model created by naviHealth, which UnitedHealth acquired in 2020, to deny claims. The lawsuit alleged that the model, named nH Predict, had a 90% error rate. A spokesperson for UnitedHealth denied that they use the model to deny claims when questioned by The Guardian.

Secret payments to nursing homes

In May 2025, The Guardian published an investigative report which uncovered a systemic effort by UnitedHealth to secretly pay nursing homes bonuses to deny hospital transfers for nursing home residents who needed immediate hospital care. Other tactics uncovered by The Guardian include UnitedHealth managers pressuring nurse practitioners to persuade members to sign onto Do not resuscitate agreements and payments for leaking confidential patient data to UnitedHealth sales teams. In June, UnitedHealth sued The Guardian for defamation over the findings of their article.

Campaign against critics

In July 2025, a New York Times investigation revealed that UnitedHealth Group, with the help of the law firm Clare Locke, had made legal threats against journalists, social media users and healthcare professionals who criticized their policies and practices. UnitedHealth also made take-down requests to social media companies hosting content critical of them.

Massachusetts Medicaid fraud lawsuit

In May 2026, the state of Massachusetts sued UnitedHealth for defrauding MassHealth, the state's Medicaid program, of $100 million by making older patients seem more seriously ill than they actually were.

Foundations

Foundations affiliated with UnitedHealth Group include the UnitedHealth Foundation (UHF) and the UnitedHealthcare Children's Foundation (UHCCF), both of which were established in 1999.

UHF pledged $100 million over ten years to fund scholarships and workforce development programs focused on increasing ethnic and racial diversity within the health care industry. UHF's investment will support 10,000 physicians from underrepresented communities: 5,000 students with a primary care focus and 5,000 physicians who want to advance careers in mental health, nursing, midwifery and medicine. The work of this fund is part of a broader initiative in which UnitedHealth Group has teamed up with nine organizations to provide scholarships to more than 3,000 students through the Diverse Scholars Initiative.

UHCCF administers grants to help pay for medical costs for families with coverage gaps. According to UHCCF, the foundation raises money for medical grants by selling gift items such as backpacks, books, cards, and games, some of which are created by children.

Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗

Wikidata ↗

sektörHealth Care endüstriHealth Care çalışanlar390.000 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06
Gelir$447.57B
2021-12-31 → 2025-12-31
Hisse Başına Kâr$13.23
2021-12-31 → 2025-12-31
Serbest Nakit Akışı$16.07B
2021-12-31 → 2025-12-31
Net kar marjı3.1%
2021-12-31 → 2025-12-31
Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik 5 Yıllık trend UNH 5Y ort. Akran Ortalaması Sonuç
P/E (TTM) 26.8 · 33.8 Düşük değerli
F/S (TTM) 0.8 · 0.7 Daha pahalı
F/D (MRQ) 3.6 · 3.9 Adil değer
EV / EBITDA 22.3 · 16.1 Aşırı değerli
Fiyat / Serbest Nakit Akışı (TTM) 16.0 · · ·
Fiyat / Nakit Akışı (TTM) 14.0 · 15.6 Adil değer
EV / Gelir (TTM) 0.9 · · ·
EV / FCF (TTM) 17.6 · · ·
Fiyat / Maddi Defter Değeri (MRQ) 4.5 · · ·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

13
Temettü Verimi2.1%
Temettü Ödeme Oranı65.7%
Yıllıklaştırılmış Ödeme≈$9.28Üç Aylık Ödeme
5 Yıllık Temettü CAGR≈12.1%Hisse başına, bölünmeye göre ayarlanmış
Büyüme Serisi≈16Ardışık temettü büyüme yılları
Ex-tarihiMiktarPara BirimiTemettü Verimi
Eyl 14, 2026$2,32USD≈2.4%
Haz 15, 2026$2,32USD≈2.2%
Mar 9, 2026$2,21USD≈3.1%
Ara 8, 2025$2,21USD≈2.7%
Eyl 15, 2025$2,21USD≈2.5%
Haz 16, 2025$2,21USD≈2.8%
Mar 10, 2025$2,10USD≈1.7%
Ara 9, 2024$2,10USD≈1.5%
Eyl 16, 2024$2,10USD≈1.4%
Haz 17, 2024$2,10USD≈1.6%
Mar 8, 2024$1,88USD≈1.6%
Ara 1, 2023$1,88USD≈1.3%
Eyl 8, 2023$1,88USD≈1.5%
Haz 15, 2023$1,88USD≈1.5%
Mar 10, 2023$1,65USD≈1.4%
Ara 2, 2022$1,65USD≈1.2%
Eyl 9, 2022$1,65USD≈1.2%
Haz 16, 2022$1,65USD≈1.3%
Mar 11, 2022$1,45USD≈1.2%
Ara 3, 2021$1,45USD≈1.2%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14
Ort. Sürpriz 5.8%
DönemRaporEPS GerçekEPS TahminSürpriz
30 Eylül 2026 Eki 13, 2026 $4.69 $4.18 12.2%
30 Haziran 2026 Tem 16, 2026 $6.38 $4.95 28.8%
31 Mart 2026 $7.23 $6.64 8.9%
31 Aralık 2025 $2.11 $2.12 -0.57%
30 Eylül 2025 $2.92 $2.82 3.5%
30 Haziran 2025 $4.08 $4.53 -9.9%
31 Mart 2025 $7.20 $7.36 -2.2%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15
Gelir Tablosu 14
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue $447.57B$400.28B$371.62B$324.16B$287.60B$257.14B$242.16B$226.25B$201.16B$184.84B$157.11B$130.47B
Cost of Revenue $50.66B$46.69B$38.77B$33.70B$31.03B$30.75B$28.12B$27.00B$24.11B$24.42B$16.21B$3.83B
SG&A Expense $59.59B$53.01B$54.63B$47.78B$42.58B$41.70B$35.19B$34.07B$29.56B$28.40B$24.31B$21.26B
Operating Expenses $428.60B$367.99B$339.26B$295.73B$263.63B$234.74B$222.47B$208.90B$185.95B$171.91B$146.09B$120.20B
Operating Income $18.96B$32.29B$32.36B$28.43B$23.97B$22.41B$19.68B$17.34B$15.21B$12.93B$11.02B$10.27B
Interest Expense $4.00B$3.91B$3.25B$2.09B$1.66B$1.66B$1.70B$1.40B$1.19B$1.07B$790M$618M
Pretax Income $14.70B$20.07B$29.11B$26.34B$22.31B$20.74B$17.98B$15.94B$14.02B$11.86B$10.23B$9.66B
Income Tax $1.89B$4.83B$5.97B$5.70B$4.58B$4.97B$3.74B$3.56B$3.20B$4.79B$4.36B$4.04B
Net Income $12.06B$14.40B$22.38B$20.12B$17.29B$15.40B$13.84B$11.99B$10.56B$7.02B$5.81B$5.62B
EPS (Basic) $13.28$15.64$24.12$21.47$18.33$16.23$14.55$12.45$10.95$7.37$6.10$5.78
EPS (Diluted) $13.23$15.51$23.86$21.18$18.08$16.03$14.33$12.19$10.72$7.25$6.01$5.70
Shares (Basic) 908,000,000921,000,000928,000,000937,000,000943,000,000949,000,000951,000,000963,000,000964,000,000952,000,000953,000,000972,000,000
Shares (Diluted) 911,000,000929,000,000938,000,000950,000,000956,000,000961,000,000966,000,000983,000,000985,000,000968,000,000967,000,000986,000,000
EBITDA $18.96B$32.29B$32.36B$28.43B$23.97B$22.41B$19.68B$17.34B$15.21B$12.93B$11.02B$10.27B
Bilanço 26
Metrik Eğilim 202520242023202220212020201920182017201620152014
Cash & Equivalents $24.36B$25.31B$25.43B$23.36B$21.38B$16.92B$10.98B$10.87B$11.98B$10.43B$10.92B$7.50B
Short-term Investments $3.76B$3.80B$4.20B$4.55B$2.53B$2.86B$3.26B$3.46B$3.51B$2.85B$1.99B$1.74B
Receivables $23.02B$22.36B$21.28B$17.68B$14.22B$12.87B$11.82B$11.39B$9.57B$8.15B$6.52B$4.25B
Inventory $3.30B$3.80B$2.80B$3.50B$2.90B·······
Prepaid Expense $9.75B$8.21B$6.08B$6.62B$5.32B$4.46B$3.85B$3.09B$2.66B$1.85B$2.41B$1.05B
Current Assets $90.58B$85.78B$78.44B$69.07B$61.76B$53.72B$42.63B$38.69B$37.08B$33.88B$31.64B$23.56B
PP&E (Net) $10.76B$10.55B$11.45B$10.13B$8.97B$8.63B$8.70B$8.46B$7.01B$5.90B$4.86B$4.42B
Accum. Depreciation $7.55B$6.97B$7.04B$6.93B$5.99B$5.23B$5.00B$4.14B$3.69B$3.75B$3.17B$2.95B
Goodwill $110.50B$106.73B$103.73B$93.35B$75.80B$71.34B$65.66B$58.91B$54.56B$47.58B$44.45B$32.94B
Intangibles $20.47B$23.27B$15.19B$14.40B$10.04B$10.86B$10.35B$9.32B$8.49B$8.54B$8.39B$3.67B
Other Non-current Assets $23.01B$19.59B$17.30B$15.03B$12.53B$11.51B$9.33B$4.33B$3.58B$3.04B$3.12B$2.97B
Total Assets $309.58B$298.28B$273.72B$245.71B$212.21B$197.29B$173.89B$152.22B$139.06B$122.81B$111.25B$86.30B
Accounts Payable $38.03B$34.34B$31.96B$27.71B$24.64B$22.50B$19.00B$16.70B$15.18B$13.36B$11.99B$9.25B
Current Liabilities $114.90B$103.77B$99.05B$89.24B$78.29B$72.42B$61.78B$53.21B$50.46B$49.25B$42.90B$30.62B
Deferred Tax $2.42B$3.62B$3.02B$2.77B$3.27B$3.37B$2.99B$2.47B$2.18B$2.76B$3.59B$2.06B
Other Non-current Liabilities $18.25B$15.94B$14.46B$12.84B$11.79B$12.31B$10.14B$5.73B$5.56B$4.83B$1.48B$1.36B
Total Liabilities $207.88B$195.69B$174.80B$159.36B$135.73B$126.75B$111.73B$95.99B$87.04B$82.62B$75.79B$52.54B
Long-term Debt ····$46.00B$43.47B$40.68B$36.55B$31.69B$32.97B$31.96B$17.41B
Total Debt $72.32B$72.36B$58.26B$54.51B$46.00B$43.47B$40.68B$36.55B$31.69B$32.97B$32.09B$17.41B
Common Stock $9M$9M$9M$9M$10M$10M$9M$10M$10M$10M$10M$10M
Paid-in Capital $559M$0$0·$0$0$7M$0$1.70B$0$29M$0
Retained Earnings $95.60B$96.04B$95.77B$86.16B$77.13B$69.30B$61.18B$55.85B$48.73B$40.95B$37.12B$33.84B
AOCI $-2.06B$-3.39B$-7.03B$-8.39B$-5.38B$-3.81B$-3.58B$-4.16B$-2.67B$-2.68B$-3.33B$-1.39B
Stockholders' Equity $100.09B$98.27B$94.42B$81.45B$75.05B$68.33B$60.44B$54.32B$49.83B$38.18B$33.73B$32.45B
Liabilities + Equity $309.58B$298.28B$273.72B$245.71B$212.21B$197.29B$173.89B$152.22B$139.06B$122.81B$111.25B$86.38B
Shares Outstanding 906,000,000915,000,000924,000,000934,000,000941,000,000946,000,000948,000,000960,000,000969,000,000952,000,000953,000,000954,000,000
Nakit Akışı 18
Metrik Eğilim 202520242023202220212020201920182017201620152014
D&A $4.36B$4.10B$3.97B$3.40B$3.10B$2.89B$2.72B$2.43B$2.25B$2.06B$1.69B$1.48B
Stock-based Comp $971M$1.02B$1.06B$925M$800M$679M$697M$638M$597M$485M$406M$364M
Deferred Tax $-1.75B$-296M$-245M$-673M$130M$-8M$230M$42M$-965M$81M$-73M$-117M
Amort. of Intangibles $1.70B$1.70B$1.60B$1.30B$1.20B$1.10B$1.00B$898M$896M$882M$650M$524M
Operating Cash Flow $19.70B$24.20B$29.07B$26.21B$22.34B$22.17B$18.46B$15.71B$13.60B$9.79B$9.74B$8.05B
CapEx $3.62B$3.50B$3.39B$2.80B$2.45B$2.05B$2.07B$2.06B$2.02B$1.71B$1.56B$1.52B
Investing Cash Flow $-8.69B$-20.53B$-15.57B$-28.48B$-10.37B$-12.53B$-12.70B$-12.38B$-8.60B$-9.36B$-18.39B$-2.53B
Debt Issued $2.97B$17.81B$6.39B$14.82B$6.93B$4.86B$5.44B$6.93B$5.29B$3.97B$11.98B$2.00B
Net Debt Issued $-81M$14.81B$4.27B$11.80B$3.78B$1.71B$3.69B$4.33B$893M$1.37B$10.94B$1.19B
Stock Issued $827M$1.85B$1.35B$1.25B$1.35B$1.44B$1.04B$838M$688M$429M$402M$462M
Stock Repurchased $5.54B$9.00B$8.00B$7.00B$5.00B$4.25B$5.50B$4.50B$1.50B$1.28B$1.20B$4.01B
Net Stock Activity $-4.72B$-7.15B$-6.65B$-5.75B$-3.65B$-2.81B$-4.46B$-3.66B$-812M$-851M$-798M$-3.55B
Dividends Paid $7.92B$7.53B$6.76B$5.99B$5.28B$4.58B$3.93B$3.32B$2.77B$2.26B$1.79B$1.36B
Financing Cash Flow $-11.64B$-3.51B$-11.53B$4.23B$-7.46B$-3.59B$-5.62B$-4.37B$-3.44B$-1.01B$12.24B$-5.29B
Net Change in Cash $-947M$-115M$2.06B$1.99B$4.45B$5.94B$119M$-1.11B$1.55B$-493M$3.43B$219M
Taxes Paid $3.71B$4.62B$6.08B$5.22B$3.97B$4.93B$3.54B$3.26B$4.00B$4.73B$4.40B$4.02B
Free Cash Flow $16.07B$20.70B$25.68B$23.40B$19.89B$20.12B$16.39B$13.65B$11.57B$8.09B$8.18B$6.53B
Levered FCF $12.59B$17.74B$23.10B$21.76B$18.57B$18.86B$15.04B$12.56B$10.66B$7.45B$7.73B$6.17B
Kârlılık 7
Metrik Eğilim 202520242023202220212020201920182017201620152014
Operating Margin 4.2%8.1%8.7%8.8%8.3%8.7%8.1%7.7%7.6%7.0%7.0%7.9%
Net Margin 2.7%3.6%6.0%6.2%6.0%6.0%5.7%5.3%5.2%3.8%3.7%4.3%
Pretax Margin 3.3%5.0%7.8%8.1%7.8%8.1%7.4%7.0%7.0%6.4%6.5%7.4%
EBITDA Margin 4.2%8.1%8.7%8.8%8.3%8.7%8.1%7.7%7.6%7.0%7.0%7.9%
ROA 4.0%4.8%8.6%8.8%8.4%8.3%8.5%8.2%8.1%6.0%5.9%6.7%
ROE 12.0%14.5%24.3%25.2%23.3%22.6%23.4%22.4%21.7%18.5%17.4%17.3%
ROIC 9.6%14.4%16.9%16.4%15.7%15.2%15.4%14.8%14.4%10.8%9.6%12.0%
Likidite ve Solventlik 5
Metrik Eğilim 202520242023202220212020201920182017201620152014
Current Ratio 0.80.80.80.80.80.70.70.70.70.70.70.8
Quick Ratio 0.40.50.50.50.50.50.40.50.50.40.50.4
Debt / Equity 0.70.70.60.70.60.60.70.70.60.91.00.5
LT Debt / Equity 0.70.70.60.70.60.60.60.60.60.70.80.5
Interest Coverage 4.78.310.013.614.413.511.612.412.812.114.016.6
Verimlilik 3
Metrik Eğilim 202520242023202220212020201920182017201620152014
Asset Turnover 1.51.31.41.41.41.41.51.61.51.61.61.6
Inventory Turnover 14.314.112.310.5········
Receivables Turnover 19.718.319.120.321.220.820.921.622.725.229.235.7
Hisse Başına 7
Metrik Eğilim 202520242023202220212020201920182017201620152014
Book Value / Share $110.47$107.40$102.19$87.21$79.75$72.23$63.75$56.58$51.43$40.10$35.39$34.02
Revenue / Share $491.29$430.87$396.19$341.22$300.83$267.58$250.68$230.16$204.22$190.95$162.47$132.33
Cash Flow / Share $21.62$26.05$30.99$27.59$23.37$23.07$19.11$15.98$13.80$10.12$10.07$8.17
Cash / Share $26.89$27.66$27.52$25.02$22.72$17.89$11.59$11.32$12.36$10.96$11.46$7.86
Dividend / Share ········$2.88$2.38$1.88$1.41
Dividend Paid / Share $8.73$8.18$7.29$6.40$5.60$4.83$4.14$3.45$2.88$2.38$1.88$1.41
EPS (TTM) $13.23$15.51$23.86$21.18$18.08$16.03$14.33$12.19$10.72$7.25$6.01$5.70
Büyüme Oranları 10
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue YoY 11.8%7.7%14.6%12.7%11.8%·······
Revenue CAGR 3Y 11.3%11.7%13.1%·········
Revenue CAGR 5Y 11.7%···········
EPS YoY -14.7%-35.0%12.7%17.2%12.8%·······
EPS CAGR 3Y -14.5%-5.0%14.2%·········
EPS CAGR 5Y -3.8%···········
Net Income YoY -16.3%-35.6%11.2%16.4%12.2%·······
Net Income CAGR 3Y -15.7%-5.9%13.3%·········
Net Income CAGR 5Y -4.8%···········
Dividends Paid CAGR 5Y 11.6%···········
Değerleme (TTM) 16
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue TTM $447.57B$400.28B$371.62B$324.16B$287.60B$257.14B$242.16B$226.25B$201.16B$184.84B$157.11B$130.47B
Net Income TTM $12.06B$14.40B$22.38B$20.12B$17.29B$15.40B$13.84B$11.99B$10.56B$7.02B$5.81B$5.62B
Market Cap $299.08B$462.86B$486.46B$495.19B$472.51B$331.74B$278.69B$239.16B$213.63B$152.36B$112.11B$96.44B
Enterprise Value $343.28B$506.11B$515.09B$521.79B$494.61B$355.43B$305.13B$261.39B$229.83B$172.05B$131.29B$104.61B
P/E 25.032.622.125.027.821.920.520.420.622.119.617.7
P/S 0.71.21.31.51.61.31.21.11.10.80.70.7
P/B 3.04.75.26.16.34.94.64.44.34.03.33.0
P / Cash Flow 15.219.116.718.921.115.015.115.215.715.611.512.0
P / FCF 18.622.418.921.223.816.517.017.518.518.813.714.8
EV / EBITDA 18.115.715.918.420.615.915.515.115.113.311.910.2
EV / FCF 21.424.420.122.324.917.718.619.119.921.316.016.0
EV / Revenue 0.81.31.41.61.71.41.31.21.10.90.80.8
Dividend Yield 2.6%1.6%1.4%1.2%1.1%1.4%1.4%1.4%1.3%1.5%1.6%1.4%
Earnings Yield 4.0%3.1%4.5%4.0%3.6%4.6%4.9%4.9%4.9%4.5%5.1%5.6%
Payout Ratio 65.7%52.3%30.2%29.8%30.6%29.8%28.4%27.7%26.3%32.2%30.7%24.2%
Annual Payout $7.92B$7.53B$6.76B$5.99B$5.28B$4.58B$3.93B$3.32B$2.77B$2.26B$1.79B$1.36B

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16
Metrik 2025-12-312025-06-302025-03-312024-12-312024-09-30
Gelir $447.57B · · $400.28B ·
Faaliyet Kâr Marjı % 4.2% · · 8.1% ·
Net Gelir $12.06B · · $14.40B ·
Seyreltilmiş Hisse Başı Kâr $13.23 · · $15.51 ·

Kurumsal Sahipler (13F) 3.691 dosya · $370.4B toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 3.691
Tutulan Değer $370.4B
Yeni pozisyonlar 515
Çıkan pozisyonlar 126
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
Yeni pozisyonlar Çıkan pozisyonlar Artırıldı Azaldı Net hisse senedi değişimi
515 (+259 önceki Ç'ye göre) 126 (-253 önceki Ç'ye göre) 1.328 (+105 önceki Ç'ye göre) 1.319 (-89 önceki Ç'ye göre) +17.1M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum Değer Hisse senetleri % izlenen 13F'nin Tür
BlackRock, Inc. $31.946.594.368 76.863.061 8,62% Hisse senetleri
VANGUARD GROUP INC $30.238.161.829 91.600.260 8,16% Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC $24.651.649.136 59.311.525 6,65% Hisse senetleri
STATE STREET CORP $18.966.554.763 45.633.267 5,12% Hisse senetleri
Capital World Investors $12.422.776.956 29.887.932 3,35% Hisse senetleri
FMR LLC $11.634.728.621 27.992.995 3,14% Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC $10.175.966.547 24.483.234 2,75% Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC $9.008.139.395 21.751.937 2,43% Hisse senetleri
JPMORGAN CHASE & CO $8.499.696.736 20.246.047 2,29% Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8.242.777.944 19.830.588 2,23% Hisse senetleri
MORGAN STANLEY $6.149.436.946 14.795.456 1,66% Hisse senetleri
NORGES BANK $5.293.868.088 12.736.973 1,43% Hisse senetleri
Bank of New York Mellon Corp $4.449.316.683 10.704.994 1,20% Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP $4.436.922.985 10.675.175 1,20% Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP $4.403.973.917 10.595.900 1,19% Alım opsiyonu
Capital Research Global Investors $4.378.631.657 10.534.177 1,18% Hisse senetleri
BANK OF AMERICA CORP /DE/ $4.046.521.317 9.735.874 1,09% Hisse senetleri
Fisher Asset Management, LLC $3.774.863.715 9.082.269 1,02% Hisse senetleri
Dodge & Cox $3.770.702.593 9.072.258 1,02% Hisse senetleri
NORTHERN TRUST CORP $3.641.357.289 8.761.055 0,98% Hisse senetleri
FRANKLIN RESOURCES INC $3.592.618.078 8.643.789 0,97% Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP $3.484.641.920 8.384.000 0,94% Satım opsiyonu
JANE STREET GROUP, LLC $3.473.960.229 8.358.300 0,94% Alım opsiyonu
Capital International Investors $3.237.872.783 7.789.028 0,87% Hisse senetleri
GOLDMAN SACHS GROUP INC $2.898.658.338 6.974.132 0,78% Hisse senetleri
Invesco Ltd. $2.850.799.411 6.858.984 0,77% Hisse senetleri
CITADEL ADVISORS LLC $2.632.849.798 6.334.600 0,71% Alım opsiyonu
Sanders Capital, LLC $2.451.649.249 5.898.634 0,66% Hisse senetleri
Legal & General Group Plc $2.444.927.690 5.882.462 0,66% Hisse senetleri
EAGLE CAPITAL MANAGEMENT LLC $2.399.442.912 5.773.026 0,65% Hisse senetleri
CITADEL ADVISORS LLC $2.340.745.034 5.631.800 0,63% Satım opsiyonu
ROYAL BANK OF CANADA $2.153.793.000 5.181.995 0,58% Hisse senetleri
VANGUARD FIDUCIARY TRUST CO $2.119.167.278 5.098.687 0,57% Hisse senetleri
Amundi $2.100.894.352 5.054.732 0,57% Hisse senetleri
ALLIANCEBERNSTEIN L.P. $2.075.268.358 7.669.420 0,56% Hisse senetleri
JANE STREET GROUP, LLC $2.055.124.098 4.944.600 0,55% Satım opsiyonu
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $2.013.971.605 7.442.890 0,54% Hisse senetleri
DIMENSIONAL FUND ADVISORS LP $1.946.353.016 4.682.496 0,53% Hisse senetleri
AMERIPRISE FINANCIAL INC $1.875.407.666 4.510.354 0,51% Hisse senetleri
HSBC HOLDINGS PLC $1.662.111.390 3.992.237 0,45% Hisse senetleri
Nuveen, LLC $1.555.270.921 3.741.960 0,42% Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS $1.526.781.892 3.673.416 0,41% Hisse senetleri
WELLS FARGO & COMPANY/MN $1.503.990.279 3.618.579 0,41% Hisse senetleri
UBS Group AG $1.479.893.008 3.560.602 0,40% Hisse senetleri
BARCLAYS PLC $1.424.488.286 3.427.299 0,38% Hisse senetleri
RAYMOND JAMES FINANCIAL INC $1.374.213.210 3.306.337 0,37% Hisse senetleri
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $1.251.138.985 3.010.223 0,34% Hisse senetleri
Grantham, Mayo, Van Otterloo & Co. LLC $1.174.164.878 2.825.022 0,32% Hisse senetleri
UBS Group AG $1.092.471.817 2.628.472 0,29% Alım opsiyonu
Mitsubishi UFJ Asset Management Co., Ltd. $1.065.664.884 2.563.973 0,29% Hisse senetleri

Tüm 3.691 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 2 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi Dosyalandı Hisse Durum Amaç Başvuru
UnitedHealth Group Incorporated ×3 başvurular 15 Ocak 2021 · İlk başvuru M&A / satış SEC
Ingenix, Inc., UnitedHealth Group Incorporated 05 Haziran 2006 · İlk başvuru M&A / satış SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 64 içeriden öğrenenler · 39 yöneticiler · 27 yönetim kurulu üyeleri

19
İçeriden Öğrenen Rol Son işlem Sahip olunan hisse senetleri Alımlar 12ay Satışlar 12ay Net 12ay
Patrick Hugh Conway Chief Executive Officer, Optum 22 Eylül 2026 A 15.419 0 3 $-944.910
Timothy John Noel Chief Executive Officer, UHC 22 Eylül 2026 A 17.735 0 0 $0
Stephen J Hemsley CEO, UHG 22 Eylül 2026 A 177.690 0 0 $0
Heather Cianfrocco Chief Executive Officer, Optum 18 Mart 2025 A 22.438 0 0 $0
Andrew Witty CEO, UHG 18 Mart 2025 A 112.162 0 0 $0
Brian R Thompson CEO, UnitedHealthcare 24 Eylül 2024 A 32.675 0 0 $0
David S Wichmann Chief Executive Officer 16 Aralık 2020 F 967.872 0 0 $0
Steven H Nelson EVP & CEO, UnitedHealthcare 25 Haziran 2019 A 38.502 0 0 $0
Larry C Renfro Vice Chmn, UHG and CEO, Optum 26 Haziran 2018 A 153.790 0 0 $0
Gail Boudreaux EVP & CEO, UnitedHealthcare 23 Eylül 2014 A 184.732 0 0 $0
George Lawrence Mikan III EVP UHG & CEO, Optum 05 Haziran 2011 F 209.279 0 0 $0
Tracy L Bahl CEO, Uniprise 07 Kasım 2006 A 4.230 0 0 $0
Robert J Sheehy CEO, UnitedHealthcare 07 Kasım 2006 A 3.009 0 0 $0
MCGUIRE WILLIAM W Chief Executive Officer 07 Kasım 2006 A 644.862 0 0 $0
Channing R Wheeler CEO, Uniprise, Inc. 28 Kasım 2003 J 8.356 0 0 $0
Wayne S Deveydt Chief Financial Officer 22 Eylül 2026 A 18.676 0 0 $0
John F Rex President & CFO 24 Haziran 2025 A 203.898 0 0 $0
Patrick J Erlandson Chief Financial Officer 02 Mayıs 2006 A 7.083 0 0 $0
Dirk C Mcmahon President & COO, UHG 19 Mart 2024 A 70.547 0 0 $0
Dennis Andrew Stankiewicz Chief Accounting Officer 22 Eylül 2026 A 10.109 0 0 $0
Christopher R Zaetta EVP & Chief Legal Officer 22 Eylül 2026 A 15.927 0 0 $0
Erin Mcsweeney EVP & Chief People Officer 22 Eylül 2026 A 15.654 0 0 $0
Thomas E Roos Chief Accounting Officer 23 Şubat 2026 A 31.284 0 0 $0
Rupert M Bondy EVP & Chief Legal Officer 19 Mart 2024 A 9.607 0 0 $0
Marianne D Short EVP & Chief Legal Officer 25 Şubat 2022 F 138.315 0 0 $0
Patricia L Lewis EVP and Chief HR Officer 13 Şubat 2022 F 8.901 0 0 $0
Ellen D Wilson Executive Vice President 24 Mart 2020 A 58.387 0 0 $0
Eric S Rangen Sr VP & Chief Acctg Officer 24 Haziran 2015 A 11.577 0 0 $0
Lori Sweere EVP, Human Capital 10 Mayıs 2013 S 70.661 0 0 $0
Richard N Baer EVP & Chief Legal Officer 28 Aralık 2012 F 63.880 0 0 $0
Reed Vaughn Tuckson EVP & Chief of Medical Affairs 05 Haziran 2012 F 116.886 0 0 $0
William A Munsell EVP, UnitedHealth Group 05 Haziran 2012 F 268.167 0 0 $0
Anthony Welters EVP, UnitedHealth Group 05 Haziran 2012 F 119.909 0 0 $0
Christopher James Walsh EVP and General Counsel 24 Mayıs 2011 A 101.338 0 0 $0
Mitchell Eliot Zamoff EVP and General Counsel 24 Mayıs 2011 A 113.613 0 0 $0
Thomas L Strickland EVP & Chief Legal Officer 05 Haziran 2008 A 147.182 0 0 $0
Richard H Anderson EVP, Pres, Commercial Svcs Grp 28 Mayıs 2007 A 40.606 0 0 $0
Lois E Quam EVP & Pres, Pub & Sr Mkt Grp 28 Mayıs 2007 A 13.915 0 0 $0
Forrest Gregory Burke Acting General Counsel 17 Nisan 2007 A · 0 0 $0
Frederick William Mcnabb III Yönetim kurulu üyesi 01 Ekim 2026 A 15.810 0 0 $0
Kristen Gil Yönetim kurulu üyesi 01 Ekim 2026 A 2.867 0 0 $0
Rice Valerie Montgomery MD Yönetim kurulu üyesi 01 Ekim 2026 A 8.180 0 0 $0
John H Noseworthy Yönetim kurulu üyesi 01 Ekim 2026 A 7.902 0 0 $0
Charles D. Baker Yönetim kurulu üyesi 01 Ekim 2026 A 2.668 0 0 $0
Timothy Patrick Flynn Yönetim kurulu üyesi 01 Ekim 2026 A 11.205 0 0 $0
Scott Gottlieb Yönetim kurulu üyesi 01 Ekim 2026 A 921 0 0 $0
Paul R Garcia Yönetim kurulu üyesi 01 Ekim 2026 A 4.180 0 0 $0
Michele J Hooper Yönetim kurulu üyesi 01 Nisan 2026 A 41.792 0 0 $0
BURKE RICHARD T Yönetim kurulu üyesi 19 Mayıs 2022 S 1.215.000 0 0 $0
Gail R Wilensky Yönetim kurulu üyesi 01 Nisan 2022 A 24.690 0 0 $0
Glenn M Renwick Yönetim kurulu üyesi 01 Nisan 2021 A 85.130 0 0 $0
BALLARD WILLIAM C JR Yönetim kurulu üyesi 01 Nisan 2020 A 62.266 0 0 $0
Kenneth Irwin Shine Yönetim kurulu üyesi 13 Aralık 2018 A 29.250 0 0 $0
Rodger A Lawson Yönetim kurulu üyesi 02 Nisan 2018 A 28.035 0 0 $0
Robert J Darretta Yönetim kurulu üyesi 03 Nisan 2017 A 54.480 0 0 $0
Edson De Godoy Bueno Yönetim kurulu üyesi 08 Şubat 2017 A 188.305 0 0 $0
LEATHERDALE DOUGLAS W Yönetim kurulu üyesi 01 Nisan 2015 A 921.644 0 0 $0
Mary Oneil Mundinger Yönetim kurulu üyesi 05 Haziran 2008 A 32.000 0 0 $0
Thomas H Kean Yönetim kurulu üyesi 05 Haziran 2008 A 44.000 0 0 $0
JOHNSON JAMES A /DC/ Yönetim kurulu üyesi 05 Haziran 2008 A 0 0 0 $0
RYAN ROBERT L Yönetim kurulu üyesi 05 Haziran 2008 A 16.000 0 0 $0
Donna E Shalala Yönetim kurulu üyesi 02 Nisan 2007 A 0 0 0 $0
SPEARS WILLIAM G Yönetim kurulu üyesi 02 Ekim 2006 A 64.896 0 0 $0
LUBBEN DAVID J · 31 Ekim 2005 A 1.761 0 0 $0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 190 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon Ağırlık Birimler Tarih itibarıyla Kaynak
IHF · iShares Trust 20,07% 677.912 SH 11 Eylül 2026 Günlük
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 5,85% 1.281 NS 31 Temmuz 2026 N-PORT
IYH · iShares Trust 5,65% 528.565 SH 11 Eylül 2026 Günlük
DOGG · First Trust Exchange-Traded Fund IV 5,59% 11.977 NS 31 Temmuz 2026 N-PORT
VHT · VANGUARD WORLD FUND 5,56% 2.728.542 SH 19 Ağustos 2026 Günlük
FHLC · FIDELITY COVINGTON TRUST 5,44% 431.779 NS 31 Temmuz 2026 N-PORT
DJD · Invesco Exchange-Traded Fund Trust 5,06% 63.097 SH 23 Ekim 2026 Günlük
JXX · Janus Detroit Street Trust 5,04% 3.245 NS 31 Temmuz 2026 N-PORT
DJIA · Global X Funds 4,75% 21.103 NS 31 Temmuz 2026 N-PORT
DYLG · Global X Funds 4,72% 704 NS 31 Temmuz 2026 N-PORT
FLAG · Global X Funds 4,39% 180 NS 31 Temmuz 2026 N-PORT
CURE · Direxion Shares ETF Trust 4,31% 17.869 NS 31 Temmuz 2026 N-PORT
DDDD · Tidal Trust II 4,22% 668 NS 31 Temmuz 2026 N-PORT
IXJ · iShares Trust 4,01% 428.796 SH 11 Eylül 2026 Günlük
EQIN · Columbia ETF Trust I 3,97% 29.103 NS 31 Temmuz 2026 N-PORT
DVGR · EA Series Trust 3,86% 1.633 NS 31 Temmuz 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 3,63% 160.472 SH 23 Ekim 2026 Günlük
BKDV · BNY Mellon ETF Trust II 2,96% 131.299 NS 31 Temmuz 2026 N-PORT
VEGN · ETF Series Solutions 2,73% 11.696 NS 31 Temmuz 2026 N-PORT
TBG · EA Series Trust 2,67% 16.761 NS 31 Temmuz 2026 N-PORT
CBLS · Elevation Series Trust 2,64% 3.546 NS 31 Temmuz 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 2,38% 580.990 SH 23 Ekim 2026 Günlük
SNPV · DBX ETF Trust 2,25% 15.879 NS 31 Ağustos 2026 N-PORT
DUSA · Davis Fundamental ETF Trust 2,17% 66.700 NS 31 Temmuz 2026 N-PORT
MTUM · iShares Trust 2,08% 1.301.923 SH 11 Eylül 2026 Günlük
FDIV · EA Series Trust 2,01% 2.839 NS 31 Temmuz 2026 N-PORT
SPMO · Invesco Exchange-Traded Fund Trust … 1,94% 984.721 SH 23 Ekim 2026 Günlük
HGRO · ETF Opportunities Trust 1,92% 5.834 NS 31 Temmuz 2026 N-PORT
MGV · VANGUARD WORLD FUND 1,78% 570.801 SH 19 Ağustos 2026 Günlük
JGLO · J.P. Morgan Exchange-Traded Fund Tr… 1,70% 273.276 NS 31 Temmuz 2026 N-PORT
SRHQ · Elevation Series Trust 1,69% 8.633 NS 31 Temmuz 2026 N-PORT
DGRO · iShares Trust 1,66% 1.832.156 SH 11 Eylül 2026 Günlük
VIG · VANGUARD SPECIALIZED FUNDS 1,65% 5.130.541 SH 19 Ağustos 2026 Günlük
RSPH · Invesco Exchange-Traded Fund Trust 1,64% 37.385 SH 23 Ekim 2026 Günlük
VYM · VANGUARD WHITEHALL FUNDS 1,56% 3.604.520 SH 19 Ağustos 2026 Günlük
DFLV · Dimensional ETF Trust 1,54% 250.908 NS 31 Temmuz 2026 N-PORT
FDRR · FIDELITY COVINGTON TRUST 1,51% 26.902 NS 31 Temmuz 2026 N-PORT
VUS · Virtus ETF Trust II 1,51% 650 NS 31 Temmuz 2026 N-PORT
ACVU · Hartford Funds Exchange-Traded Trust 1,47% 6.400 NS 31 Temmuz 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 1,45% 6.215 NS 31 Temmuz 2026 N-PORT
DFUV · Dimensional ETF Trust 1,42% 527.846 NS 31 Temmuz 2026 N-PORT
VTV · VANGUARD INDEX FUNDS 1,41% 8.635.243 SH 19 Ağustos 2026 Günlük
IUS · Invesco Exchange-Traded Self-Indexe… 1,40% 33.447 SH 23 Ekim 2026 Günlük
MEDI · Harbor ETF Trust 1,39% 1.382 NS 31 Temmuz 2026 N-PORT
BIGY · Tidal Trust II 1,39% 1.821 NS 31 Temmuz 2026 N-PORT
JDIV · J.P. Morgan Exchange-Traded Fund Tr… 1,38% 428 NS 31 Temmuz 2026 N-PORT
PFM · Invesco Exchange-Traded Fund Trust 1,34% 25.462 SH 23 Ekim 2026 Günlük
CVAR · ETF Opportunities Trust 1,32% 1.367 NS 31 Temmuz 2026 N-PORT
DWLD · Davis Fundamental ETF Trust 1,31% 19.334 NS 31 Temmuz 2026 N-PORT
FFLC · FIDELITY COVINGTON TRUST 1,31% 38.014 NS 31 Temmuz 2026 N-PORT
IWX · iShares Trust 1,30% 130.382 SH 11 Eylül 2026 Günlük
VOOV · VANGUARD ADMIRAL FUNDS 1,30% 209.110 SH 19 Ağustos 2026 Günlük
PRF · Invesco Exchange-Traded Fund Trust 1,27% 302.926 SH 23 Ekim 2026 Günlük
VMAX · Lattice Strategies Trust 1,27% 1.502 NS 31 Temmuz 2026 N-PORT
DIVB · iShares Trust 1,21% 63.584 SH 11 Eylül 2026 Günlük
FDLO · FIDELITY COVINGTON TRUST 1,20% 41.317 NS 31 Temmuz 2026 N-PORT
FVAL · FIDELITY COVINGTON TRUST 1,19% 38.160 NS 31 Temmuz 2026 N-PORT
IVE · iShares Trust 1,18% 1.508.315 SH 11 Eylül 2026 Günlük
QARP · DBX ETF Trust 1,17% 2.349 NS 31 Ağustos 2026 N-PORT
DIVD · EA Series Trust 1,16% 597 NS 31 Temmuz 2026 N-PORT
OEI · Listed Funds Trust 1,12% 1.253 NS 31 Temmuz 2026 N-PORT
IUSV · iShares Trust 1,12% 794.630 SH 11 Eylül 2026 Günlük
EQWL · Invesco Exchange-Traded Fund Trust 1,07% 71.923 SH 23 Ekim 2026 Günlük
AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… 1,06% 2.884 NS 31 Temmuz 2026 N-PORT
VONV · VANGUARD SCOTTSDALE FUNDS 1,05% 545.124 SH 19 Ağustos 2026 Günlük
LGDX · Tidal Trust III 1,04% 3.557 NS 31 Temmuz 2026 N-PORT
FBUF · Fidelity Greenwood Street Trust 1,03% 595 NS 31 Temmuz 2026 N-PORT
FHEQ · Fidelity Greenwood Street Trust 1,03% 23.120 NS 31 Temmuz 2026 N-PORT
FYEE · Fidelity Greenwood Street Trust 1,03% 5.430 NS 31 Temmuz 2026 N-PORT
ILCV · iShares Trust 1,02% 35.291 SH 11 Eylül 2026 Günlük
WCAP · Spinnaker ETF Series 1,02% 1.496 NS 31 Temmuz 2026 N-PORT
FFLV · FIDELITY COVINGTON TRUST 1,00% 396 NS 31 Temmuz 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0,98% 28.386.000 23 Ekim 2026 Günlük
JOYT · J.P. Morgan Exchange-Traded Fund Tr… 0,98% 2.306 NS 31 Temmuz 2026 N-PORT
IWD · iShares Trust 0,94% 2.006.595 SH 11 Eylül 2026 Günlük
MPLY · Strategy Shares 0,92% 353 NS 31 Temmuz 2026 N-PORT
XLG · Invesco Exchange-Traded Fund Trust 0,92% 253.921 SH 23 Ekim 2026 Günlük
EVUS · iShares Trust 0,91% 8.940 SH 11 Eylül 2026 Günlük
GLBL · Pacer Funds Trust 0,90% 24 NS 31 Temmuz 2026 N-PORT
EGLE · Global X Funds 0,87% 46 NS 31 Temmuz 2026 N-PORT
SNPE · DBX ETF Trust 0,86% 65.296 NS 31 Ağustos 2026 N-PORT
ACIO · ETF Series Solutions 0,83% 46.892 NS 31 Temmuz 2026 N-PORT
ADME · ETF Series Solutions 0,82% 5.790 NS 31 Temmuz 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,78% 35.580.000 23 Ekim 2026 Günlük
LSVD · ADVISORS' INNER CIRCLE FUND 0,77% 12.065 NS 31 Temmuz 2026 N-PORT
OEF · iShares Trust 0,74% 383.938 SH 11 Eylül 2026 Günlük
HELO · J.P. Morgan Exchange-Traded Fund Tr… 0,72% 80.708 NS 31 Temmuz 2026 N-PORT
MGC · VANGUARD WORLD FUND 0,71% 181.588 SH 19 Ağustos 2026 Günlük
CLSE · Trust for Professional Managers 0,68% 15.832 NS 31 Ağustos 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 0,68% 28.376 SH 23 Ekim 2026 Günlük
FBCG · FIDELITY COVINGTON TRUST 0,68% 113.499 NS 31 Temmuz 2026 N-PORT
INFO · Harbor ETF Trust 0,68% 13.747 NS 31 Temmuz 2026 N-PORT
QVML · Invesco Exchange-Traded Fund Trust … 0,66% 26.673 SH 23 Ekim 2026 Günlük
USCL · iShares Trust 0,66% 48.067 SH 11 Eylül 2026 Günlük
TOPC · iShares Trust 0,65% 552 SH 11 Eylül 2026 Günlük
DFSU · Dimensional ETF Trust 0,64% 35.145 NS 31 Temmuz 2026 N-PORT
ESGV · VANGUARD WORLD FUND 0,64% 204.138 SH 19 Ağustos 2026 Günlük
IWL · iShares Trust 0,62% 35.096 SH 11 Eylül 2026 Günlük
PFIG · Invesco Exchange-Traded Fund Trust … 0,62% 838.000 23 Ekim 2026 Günlük
BSCS · Invesco Exchange-Traded Self-Indexe… 0,61% 21.561.000 23 Ekim 2026 Günlük
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,61% 12.196 NS 31 Temmuz 2026 N-PORT
XVV · iShares Trust 0,60% 10.452 SH 11 Eylül 2026 Günlük
VV · VANGUARD INDEX FUNDS 0,60% 1.060.618 SH 19 Ağustos 2026 Günlük
XYLD · Global X Funds 0,59% 46.222 NS 31 Temmuz 2026 N-PORT
XRMI · Global X Funds 0,59% 711 NS 31 Temmuz 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,59% 23.589.295 SH 19 Ağustos 2026 Günlük
XYLG · Global X Funds 0,59% 909 NS 31 Temmuz 2026 N-PORT
XTR · Global X Funds 0,59% 68 NS 31 Temmuz 2026 N-PORT
SPXD · DBX ETF Trust 0,59% 107 NS 31 Ağustos 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,59% 145.489 SH 23 Ekim 2026 Günlük
PTLC · Pacer Funds Trust 0,58% 45.982 NS 31 Temmuz 2026 N-PORT
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,58% 125.037 NS 31 Temmuz 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,58% 5.382 SH 23 Ekim 2026 Günlük
XCLR · Global X Funds 0,58% 50 NS 31 Temmuz 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0,58% 76.661 NS 31 Temmuz 2026 N-PORT
TOV · EA Series Trust 0,58% 3.693 NS 31 Temmuz 2026 N-PORT
VOTE · TCW ETF Trust 0,58% 15.333 NS 31 Temmuz 2026 N-PORT
DFUS · Dimensional ETF Trust 0,55% 275.366 NS 31 Temmuz 2026 N-PORT
VONE · VANGUARD SCOTTSDALE FUNDS 0,54% 149.315 SH 19 Ağustos 2026 Günlük
PALC · Pacer Funds Trust 0,54% 2.737 NS 31 Temmuz 2026 N-PORT
IVV · iShares Trust 0,54% 11.446.549 SH 11 Eylül 2026 Günlük
SPUU · Direxion Shares ETF Trust 0,54% 3.427 NS 31 Temmuz 2026 N-PORT
OMFL · Invesco Exchange-Traded Self-Indexe… 0,53% 59.942 SH 23 Ekim 2026 Günlük
QDPL · Pacer Funds Trust 0,53% 21.871 NS 31 Temmuz 2026 N-PORT
ILCB · iShares Trust 0,53% 17.613 SH 11 Eylül 2026 Günlük
VTI · VANGUARD INDEX FUNDS 0,52% 28.835.934 SH 19 Ağustos 2026 Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS 0,52% 76.032 SH 19 Ağustos 2026 Günlük
IYY · iShares Trust 0,50% 38.951 SH 11 Eylül 2026 Günlük
IWB · iShares Trust 0,50% 625.110 SH 11 Eylül 2026 Günlük
ROUS · Lattice Strategies Trust 0,50% 8.454 NS 31 Temmuz 2026 N-PORT
FDVV · FIDELITY COVINGTON TRUST 0,50% 121.474 NS 31 Temmuz 2026 N-PORT
PHDG · Invesco Actively Managed Exchange-T… 0,49% 707 SH 23 Ekim 2026 Günlük
APUE · Trust for Professional Managers 0,48% 30.954 NS 31 Ağustos 2026 N-PORT
PEVC · Pacer Funds Trust 0,48% 28 NS 31 Temmuz 2026 N-PORT
IWV · iShares Trust 0,48% 249.175 SH 11 Eylül 2026 Günlük
ITOT · iShares Trust 0,48% 1.182.316 SH 11 Eylül 2026 Günlük
TILT · FlexShares Trust 0,48% 25.122 NS 31 Temmuz 2026 N-PORT
HCMT · Direxion Shares ETF Trust 0,47% 6.322 NS 31 Temmuz 2026 N-PORT
BSCT · Invesco Exchange-Traded Self-Indexe… 0,46% 14.409.000 23 Ekim 2026 Günlük
VFVA · VANGUARD WELLINGTON FUND 0,46% 9.451 SH 19 Ağustos 2026 Günlük
AFLG · First Trust Exchange-Traded Fund VI… 0,45% 8.772 NS 31 Ağustos 2026 N-PORT
ESGU · iShares Trust 0,44% 202.733 SH 11 Eylül 2026 Günlük
SPXL · Direxion Shares ETF Trust 0,44% 70.995 NS 31 Temmuz 2026 N-PORT
DYNF · BlackRock ETF Trust 0,44% 467.199 SH 11 Eylül 2026 Günlük
TOK · iShares Trust 0,41% 2.510 SH 11 Eylül 2026 Günlük
DFAU · Dimensional ETF Trust 0,41% 122.340 NS 31 Temmuz 2026 N-PORT
KOKU · DBX ETF Trust 0,41% 8.492 NS 31 Ağustos 2026 N-PORT
HDUS · Lattice Strategies Trust 0,40% 1.981 NS 31 Temmuz 2026 N-PORT
USMV · iShares Trust 0,40% 242.282 SH 11 Eylül 2026 Günlük
URTH · iShares, Inc. 0,39% 81.588 SH 11 Eylül 2026 Günlük
DFVX · Dimensional ETF Trust 0,39% 4.920 NS 31 Temmuz 2026 N-PORT
DCOR · Dimensional ETF Trust 0,37% 29.776 NS 31 Temmuz 2026 N-PORT
ACWI · iShares Trust 0,34% 289.261 SH 11 Eylül 2026 Günlük
CRBN · iShares Trust 0,34% 10.086 SH 11 Eylül 2026 Günlük
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,32% 755.775 SH 19 Ağustos 2026 Günlük
DFAC · Dimensional ETF Trust 0,30% 351.178 NS 31 Temmuz 2026 N-PORT
LRGF · iShares Trust 0,28% 26.776 SH 11 Eylül 2026 Günlük
VFMF · VANGUARD WELLINGTON FUND 0,27% 4.562 SH 19 Ağustos 2026 Günlük
ESMV · iShares Trust 0,27% 53 SH 11 Eylül 2026 Günlük
DXUV · Dimensional ETF Trust 0,24% 3.193 NS 31 Temmuz 2026 N-PORT
FFLG · FIDELITY COVINGTON TRUST 0,24% 3.356 NS 31 Temmuz 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,21% 499.538 SH 23 Ekim 2026 Günlük
EUSA · iShares, Inc. 0,20% 10.042 SH 11 Eylül 2026 Günlük
HEQQ · J.P. Morgan Exchange-Traded Fund Tr… 0,19% 140 NS 31 Temmuz 2026 N-PORT
VOXP · Advisors Series Trust 0,19% 27 NS 31 Temmuz 2026 N-PORT
SIZE · iShares Trust 0,17% 1.897 SH 11 Eylül 2026 Günlük
GLOF · iShares Trust 0,15% 779 SH 11 Eylül 2026 Günlük
JFLI · J.P. Morgan Exchange-Traded Fund Tr… 0,15% 171 NS 31 Temmuz 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,15% 1.635 NS 31 Temmuz 2026 N-PORT
ACWV · iShares, Inc. 0,15% 12.606 SH 11 Eylül 2026 Günlük
DEUS · DBX ETF Trust 0,14% 1.066 NS 31 Ağustos 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0,10% 1.939 SH 23 Ekim 2026 Günlük
QDEF · FlexShares Trust 0,02% 246 NS 31 Temmuz 2026 N-PORT
QDF · FlexShares Trust 0,02% 977 NS 31 Temmuz 2026 N-PORT
NPFE · Elevation Series Trust 0,01% 114 NS 31 Temmuz 2026 N-PORT
GTO · Invesco Actively Managed Exchange-T… 0,00% 7.000 20 Ekim 2026 Günlük
BIV · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
BLV · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
BSV · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
BND · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
VUSB · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
VCRB · VANGUARD MALVERN FUNDS · · 15 Temmuz 2026 Günlük
VPLS · VANGUARD MALVERN FUNDS · · 15 Temmuz 2026 Günlük
VSDB · VANGUARD MALVERN FUNDS · · 15 Temmuz 2026 Günlük
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 Temmuz 2026 Günlük
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 Temmuz 2026 Günlük
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 Temmuz 2026 Günlük
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 Temmuz 2026 Günlük
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 Temmuz 2026 Günlük
VCEB · VANGUARD WORLD FUND · · 30 Temmuz 2026 Günlük

UNH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21
derecelendirme · 33 analist AL
Medyan hedef $495.00 +18,4%
8 24,2% Güçlü Al
18 54,5% Al
7 21,2% Tut
0 0,0% Sat
0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

25 analist · 2026-10-24

Ortalama hedef $478.12 +14,4%

Şimdi Mevcut fiyat $418.09
Düşük$380.00 Ortalama$478.12 Yüksek$529.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü Piyasa Değeri P/E Gelir YoY Net Kar Marjı ROE Brüt Kar Marjı
UNH $299.08B 25.0 11.8% 2.7% 12.0% ·
ELV $77.37B 13.9 12.5% 2.8% 13.3% ·
HUM $50.90B 26.0 10.1% 0.92% 7.0% ·
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9% ·
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
CLOV · -5.1 40.3% -4.5% -26.2% ·
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%
ALHC $4.03B · 46.1% -0.02% -0.52% ·

Son Haberler Bu şirketten bahseden son manşetler

23

İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri

25

Canlı sinyal — ekrandaki tek dolu kart.

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

Kaynak: SEC 10-Q dosyalandı Ağu 10, 2026